Amanda Dehart
Psychiatric/Mental Health · Oceanside, CANPI 1851749881
Payments from drug & device makers
Across 165 payments — averaging $27.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$827
- AbbVie$620
- Neurocrine Biosciences, Inc.$558
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$487
- E.r. Squibb & Sons, L.L.C.$437
- Axsome Therapeutics, Inc.$318
- plus $1K from 11 others
What the payments were for
- Food & beverage$4,526100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 26 | $827 |
| AbbVie | 39 | $620 |
| Neurocrine Biosciences, Inc. | 17 | $558 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $487 |
| E.r. Squibb & Sons, L.L.C. | 13 | $437 |
| Axsome Therapeutics, Inc. | 6 | $318 |
| Johnson & Johnson | 5 | $264 |
| Lundbeck LLC | 9 | $197 |
| Tempus AI, Inc | 4 | $181 |
| Alkermes, Inc. | 8 | $151 |
| Supernus Pharmaceuticals, Inc. | 5 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $100 |
| Teva Pharmaceuticals USA, Inc. | 3 | $82 |
| Corium, LLC | 3 | $81 |
| Indivior Inc. | 3 | $66 |
| Tris Pharma Inc | 1 | $19 |
| Almatica Pharma LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,526 in reported general payments places this provider in the 90th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine ErLamotrigine | 12 | $2,726 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 16 | $1,212 |
| Escitalopram Oxalate | 19 | $471 |
| Quetiapine Fumarate | 26 | $388 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Oceanside
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- David OhIrvine$72K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
- Sarah KoLos Angeles$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.